Medicare Drug Price Negotiation in the United States: Implications and Unanswered Questions
- 8 December 2022
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 26 (3), 394-399
- https://doi.org/10.1016/j.jval.2022.11.015
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D InvestmentApplied Health Economics and Health Policy, 2020
- Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018JAMA, 2020
- Profitability of Large Pharmaceutical Companies Compared With Other Large Public CompaniesJAMA, 2020